NCT03078699View on ClinicalTrials.gov

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

January 1, 2014

Study Completion Date

September 1, 2016

Conditions
ThymomaThymic Tumor
Interventions
RADIATION

stereotactic body radiation therapy

A total radiation dose of 35-50 Gy was delivered to the 50% isodose line covering at least 95% of the PTV (3.5-5Gy/fraction), and a total radiation dose of 49-70 Gy was delivered to the 70% isodose line covering at least 95% of GTV (4.9-7 Gy/fraction).

Trial Locations (1)

400042

Daping Hospital, Third Military Medical University, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER

NCT03078699 - Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment | Biotech Hunter | Biotech Hunter